The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.098
Bid: 0.098
Ask: 0.1045
Change: 0.00075 (0.75%)
Spread: 0.0065 (6.633%)
Open: 0.10
High: 0.10
Low: 0.098
Prev. Close: 0.1005
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing to raise £454,822

8 Nov 2023 07:00

RNS Number : 7079S
Versarien PLC
08 November 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS AMENDED) AS IT FORMS PART OF THE DOMESTIC LAW OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED). UPON PUBLICATION OF THIS ANNOUNCMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

8 November 2023

 

Versarien plc

 

("Versarien" or the "Company")

 

Placing to raise £454,822

 

Versarien plc (AIM: VRS), the advanced materials engineering group, announces it has raised £454,822 (before expenses) by way of a placing (the "Placing") of 165,389,817 new ordinary shares in the capital of the Company ("Placing Shares") at a price of 0.275 pence per share (the "Placing Price").

 

Highlights

 

· Versarien has raised £454,822, before expenses, through the placing of 165,389,817 new ordinary shares in the capital of the Company at a price of 0.275 pence per share

· The net proceeds of the Placing will be used for corporate and working capital purposes, together with providing bridge finance to extend the Company's cash runway ahead of any funds received from asset sales

· The issue of the Placing Shares is within existing authorities granted by shareholders at the general meeting of the Company held on 30 October 2023 and therefore no shareholder approval is required for the Placing

 

Use of Proceeds and Turnaround Strategy

 

The net proceeds of the Placing will be used for corporate and working capital purposes, together with providing bridge finance to extend the Company's cash runway ahead of any funds received from asset sales.

 

Versarien continues to pursue its stated turnaround strategy:

· to maintain and strengthen the Company's scientific teams;

· use its know-how in construction and textiles to be a manufacturing light operation;

· to licence Versarien's technology, brands and manufacturing understanding; and

· divest non-core activities.

 

As previously announced, the mature businesses and the intellectual property and plant acquired from Hanwha Aerospace in 2020 continue to be marketed for sale and the Company is progressing discussions with a number of interested parties. The sale process for AAC Cyroma Limited, a manufacturer of moulded products, is the most advanced. However, the timing of any asset sales and the total quantum of the funds that may be received remains uncertain.

 

Stephen Hodge, Chief Executive Officer of Versarien, commented:

 

"As we have previously announced, the Company requires further funding to continue its turnaround strategy and we welcome the investor interest in this Placing. We continue to focus on this strategy, pursuing an encouraging pipeline of commercial and R&D projects, as well as technology licencing opportunities. We look forward to updating shareholders on continuing progress in the coming months."

 

Admission and Total Voting Rights

 

Application has been made for admission of the Placing Shares to be admitted to trading on AIM ("Admission") on or around 13 November 2023. The Placing Shares will rank pari passu in all respects with the Company's existing ordinary shares. Following Admission, the total number of ordinary shares in the Company in issue will be 496,169,507. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a light manufacturing and licensing model.

 

For further information please see: http://www.versarien.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEUPGWWGUPWPUM
Date   Source Headline
19th Oct 20204:41 pmRNSSecond Price Monitoring Extn
19th Oct 20204:35 pmRNSPrice Monitoring Extension
16th Oct 20205:18 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSAdvisory Panel
24th Sep 202012:07 pmRNSResult of AGM
23rd Sep 20207:00 amRNSPosting of Annual Report
1st Sep 20207:00 amRNSNotice of AGM
17th Aug 20207:00 amRNSUpdate re. Innovate UK Loan Agreement
11th Aug 20207:00 amRNSPreliminary Results
3rd Aug 20207:00 amRNSLaunch of Graphene Enhanced Protective Face Mask
1st Jul 20207:01 amRNS£5 million Innovate UK Loan Agreement
1st Jul 20207:00 amRNSCorporate Update and Notice of Results
19th Jun 20207:00 amRNSAppointment of Non-executive Chairman
12th Jun 20209:41 amRNSInvestor Communication
4th Jun 202012:02 pmRNSPrice Monitoring Extension
19th May 202012:07 pmRNSSecond Price Monitoring Extn
19th May 202012:02 pmRNSPrice Monitoring Extension
18th May 20204:41 pmRNSSecond Price Monitoring Extn
18th May 20204:36 pmRNSPrice Monitoring Extension
28th Apr 202011:17 amRNS2-DTech awarded grant
23rd Apr 20207:00 amRNSRolls-Royce chooses to partner with GEIC & 2-DTech
15th Apr 20205:10 pmRNSHolding(s) in Company
6th Apr 20207:00 amRNSClarification: Sharing Agreement & China JV
2nd Apr 20203:32 pmRNSHolding(s) in Company
31st Mar 202012:08 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
31st Mar 20207:00 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSHolding(s) in Company
27th Mar 20202:05 pmRNSSecond Price Monitoring Extn
27th Mar 20202:00 pmRNSPrice Monitoring Extension
26th Mar 202011:05 amRNSSecond Price Monitoring Extn
26th Mar 202011:00 amRNSPrice Monitoring Extension
25th Mar 20202:05 pmRNSSecond Price Monitoring Extn
25th Mar 20202:00 pmRNSPrice Monitoring Extension
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
25th Mar 20207:00 amRNSChina Update
23rd Mar 20203:06 pmRNSInvestor Communications
23rd Mar 20207:00 amRNSSubscription to raise £6 million
4th Mar 20204:40 pmRNSSecond Price Monitoring Extn
4th Mar 20204:35 pmRNSPrice Monitoring Extension
3rd Mar 20204:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20204:36 pmRNSPrice Monitoring Extension
28th Feb 20207:00 amRNSInvestor Communications
26th Feb 202011:05 amRNSSecond Price Monitoring Extn
26th Feb 202011:00 amRNSPrice Monitoring Extension
25th Feb 20201:48 pmRNSCorporate update
18th Feb 20204:15 pmRNSChange of Substantial Shareholding
17th Feb 20207:00 amRNSChange of Nominated Adviser and Broker
12th Feb 20204:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.